Kaltura director sells 34,601 shares at $1.30
Kaltura Inc. director Manor Eyal reported an open-market sale of 34,601 shares of Common Stock of Kaltura Inc. The shares were sold at a weighted average price of $1.3015 per share on June 25, 2026, in multiple trades between $1.27 and $1.36 per share.
Rhea-AI Filing Summary
Kaltura Inc. director Manor Eyal reported an open-market sale of 34,601 shares of Common Stock of Kaltura Inc. The shares were sold at a weighted average price of $1.3015 per share on June 25, 2026, in multiple trades between $1.27 and $1.36 per share.
After this transaction, Eyal directly holds 439,366 Kaltura shares. The sale was executed under a Rule 10b5-1 trading plan that he adopted on December 15, 2025, indicating the trades were pre-scheduled rather than decided at the last moment.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 34,601 | $1.3015 | $45K |
Footnotes (2)
- F1. The sales reported on this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 15, 2025.
- F2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.27 to $1.36, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Key Figures
Key Terms
Rule 10b5-1 trading plan regulatory
weighted average price financial
open-market sale financial
Form 4 regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Kaltura (KLTR) report for Manor Eyal?
Was the Kaltura (KLTR) insider sale made under a Rule 10b5-1 plan?
What does the price range in Manor Eyal’s Kaltura (KLTR) sale indicate?
AI-generated analysis. How Rhea-AI works. Not financial advice.